J.P. Morgan & Co. is taking an especially careful approach to its syndication of a $2.25 billion loan for Meditrust Corp., bankers close to the deal said.

To sway investors, Morgan has boosted the loan's pricing, slightly restructured its terms, and taken care to provide investors with detailed information about the loan, bankers said.

Subscribe Now

Access to authoritative analysis and perspective and our data-driven report series.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.